Edward G. Broenniman - 30 Jun 2026 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Reporting relationship: Director
Issuer ticker: AEMD
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 17:15:25 UTC
Prior SEC filing: 21 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Edward G. Broenniman by: James B. Frakes, Attorney-in-fact

Key filing fact

Edward G. Broenniman filed Form 4 for AETHLON MEDICAL INC (AEMD) on 01 Jul 2026.

Key facts

This page summarizes Edward G. Broenniman's Form 4 filing for AETHLON MEDICAL INC (AEMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 17:15.

Change

Previous filing in this sequence was filed on 21 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001284599 Primary reporting owner

BROENNIMAN EDWARD G

Relationship: Director
Address: 11555 SORRENTO VALLEY RD, STE 203, SAN DIEGO
Signature: /s/ Edward G. Broenniman by: James B. Frakes, Attorney-in-fact
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEMD transaction

Common Stock

Tax liability

Transaction value
Shares: -1,091
Change %: -4.7%
Price: $0.8200^*
Shares after: 22,363
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person forfeited 1,091 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.